Japan’s MHLW, MEXT Approve Interim Report For Ethical Clinical Research Guidelines
This article was originally published in PharmAsia News
An interim report on the review of joint ethical guidelines for epidemiological research and clinical research in Japan has been approved by MHLW and MEXT in a joint meeting on Aug. 22.
You may also be interested in...
Mexico's Genomma Lab recorded strong double-digit growth for its OTC business in the second quarter as sales more than doubled at its US consumer health operation.
New board directors named at Autolus Therapeutics, Beximco Pharmaceuticals, Tetraphase Pharmaceuticals and Vesigen.
After launching a biosimilar to Avastin (bevacizumab) in India, Cadila Pharma has now also launched rituximab and teriparatide biosimilars in its domestic market.